EGFR and prostate cancer: In addition, TAMs was reported to regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signalling pathway and promote prostate cancer stem cells self-renewal and prostate cancer metastasis via activating β-catenin/STAT3 signalling [66, 67].